Medical Sources
Every claim Pureami Tea Company makes is grounded in published, peer-reviewed medical literature. Below are the sources — all available free at PubMed.com.
Our Commitment to Transparency
The three names — Myricetin, DiHydroMyricetin, and Ampelopsin — all refer to the same flavonol. Search any of them on PubMed.com and you will find a substantial body of evidence. Qing Yun Moyeam produces this compound at 30–40% by plant weight, versus 3–6% for ordinary grades.
We do not cherry-pick studies. We have never made a claim not supported by the published literature. All citations below link directly to their source on PubMed or the original journal.
Showing all teas · anti-cancer-general. Clear filter
Qing Yun Moyeam
Ampelopsis Grossedentata — Myricetin / DiHydroMyricetin / Ampelopsin
Anti-Cancer (General)
PubMed
Myricetin demonstrated a significant protective effect against chemically-induced breast cancer in animal models, reducing tumor development.
PubMed
Myricetin was shown to stabilize a specific DNA structure (G-quadruplex) that helps suppress cancer cell replication — revealing a novel anticancer mechanism.
PubMed
This structural study showed how myricetin binds to and inhibits a bacterial protein involved in DNA replication, with implications for targeting similar pathways in cancer cells.
PubMed
Myricetin was found to block multiple enzymes (kinases) that drive tumor growth, suggesting broad-spectrum anticancer potential across several cancer types.
Disclaimer: The research cited above is provided for educational purposes only and reflects the findings of independent researchers. Pureami Tea Company does not claim that Moyeam diagnoses, treats, cures, or prevents any disease. These statements have not been evaluated by the FDA. Consult your healthcare provider before making any changes to your diet or supplement regimen.